4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-15-025769
SVP & Chief Medical Officer sold 8,940 shares at $10.54 ($94,228)
- SVP & Chief Medical Officer acquired 17,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Paolo · SVP & Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-03-10 | Exercise or conversion : show line 1 in the form | +12,500 | 34,485 | D | ||
| 2015-03-10 | Exercise or conversion : show line 2 in the form | +5,000 | 39,485 | D | ||
| 2015-03-10 | Sale : show line 3 in the form | −8,940 | $10.54 | $94,228 | 30,545 | D |
| Open-market sales · 8,940 sh · avg $10.54 · $94,228 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2015-03-10 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −12,500 | 12,500 | 25,000 | D |
| 2015-03-10 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −5,000 | 5,000 | 15,000 | D |
Loading xslF345X03/doc4.xml…